Raphael Pharmaceutical RAPH
OTC RAPH
$1.51 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Raphael Pharmaceutical (RAPH) Cash from Investing Activities (2024)

Updated

Raphael Pharmaceutical (RAPH) reported Cash from Investing Activities of -$1,000 for Q1 2024.

Analysis

Raphael Pharmaceutical (RAPH) Cash from Investing Activities (2024) Analysis & Trends

For FY2022, Raphael Pharmaceutical posted Cash from Investing Activities of -$2,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -8.30 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -2.71 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -10.22 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -1.32 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.89 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -649.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -244.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -2.03 Bn
10 Raphael Pharmaceutical 30.47 Mn 30.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -1,000.00
API Access

Raphael Pharmaceutical Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=RAPH&period=max&api_key=YOUR_API_KEY